NASDAQ:TXMD TherapeuticsMD (TXMD) Stock Forecast, Price & News $4.36 -0.04 (-0.91%) (As of 06/5/2023 ET) Add Compare Share Share Today's Range$4.30▼$4.4950-Day Range$3.42▼$4.4952-Week Range$3.25▼$11.69Volume13,423 shsAverage Volume39,907 shsMarket Capitalization$44.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About TherapeuticsMD (NASDAQ:TXMD) StockTherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.Read More Receive TXMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. Email Address TXMD Stock News HeadlinesMay 23, 2023 | seekingalpha.comTherapeuticsMD: From Fallen And Forgotten To Cash CowMay 20, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)June 6, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.May 15, 2023 | finance.yahoo.comTherapeuticsMD Announces First Quarter 2023 Financial ResultsMay 10, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Tuesday, underperforms marketMay 10, 2023 | marketwatch.comTherapeuticsMD Inc. stock rises Wednesday, still underperforms marketMay 7, 2023 | americanbankingnews.comTherapeuticsMD (NASDAQ:TXMD) Shares Down 5.4% May 3, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Monday, underperforms marketJune 6, 2023 | Vector Vest (Ad)Master Market Movements: Free Stock Analysis Report with Predictive Buy/Sell/Hold Insights!Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. April 30, 2023 | marketwatch.comTherapeuticsMD Inc. stock underperforms Friday when compared to competitorsApril 24, 2023 | americanbankingnews.com (NYSE:SNY) vs. (NYSE:TXMD) Financial SurveyApril 23, 2023 | marketwatch.comTherapeuticsMD Inc. stock outperforms market on strong trading dayApril 16, 2023 | americanbankingnews.comTherapeuticsMD (NYSE:TXMD) & Sanofi (NYSE:SNY) Financial ReviewApril 16, 2023 | americanbankingnews.comTherapeuticsMD (NYSE:TXMD) versus Sanofi (NYSE:SNY) Head-To-Head ComparisonApril 16, 2023 | americanbankingnews.comReviewing Sanofi (NYSE:SNY) & TherapeuticsMD (NYSE:TXMD)April 14, 2023 | msn.comAll You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to BuyApril 14, 2023 | americanbankingnews.comCantor Fitzgerald Equities Analysts Boost Earnings Estimates for TherapeuticsMD, Inc. (NASDAQ:TXMD)April 7, 2023 | finance.yahoo.comTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionMarch 13, 2023 | marketwatch.comTherapeuticsMD Inc. stock underperforms Monday when compared to competitorsJanuary 5, 2023 | bizjournals.comTheraputicsMD sells products rights for $153 millionJanuary 3, 2023 | finance.yahoo.comTherapeuticsMD Completes Transaction to License Its Products to Mayne PharmaDecember 26, 2022 | reuters.comTXMD.A - TherapeuticsMD Inc | Stock Price & Latest News | ReutersDecember 19, 2022 | bizjournals.comTechnology & Innovation Roundup: Company will cut 212 employees after failed buyoutDecember 16, 2022 | marketwatch.comTherapeuticsMD Inc. stock falls Thursday, underperforms marketDecember 15, 2022 | marketwatch.comTherapeuticsMD Inc. stock rises Wednesday, outperforms marketDecember 4, 2022 | finance.yahoo.comTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne PharmaNovember 15, 2022 | finance.yahoo.comTherapeuticsMD Announces Third Quarter 2022 Financial ResultsSee More Headlines TXMD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TXMD Company Calendar Last Earnings5/15/2023Today6/05/2023Next Earnings (Estimated)8/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TXMD Previous SymbolNYSEMKT:TXMD CUSIPN/A CIK25743 Webwww.therapeuticsmd.com Phone(561) 961-1900Fax561-431-3389Employees416Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$112 million Net Margins225.90% Pretax Margin23.88% Return on EquityN/A Return on Assets-106.98% Debt Debt-to-Equity RatioN/A Current Ratio1.28 Quick Ratio1.28 Sales & Book Value Annual Sales$69.96 million Price / Sales0.63 Cash FlowN/A Price / Cash FlowN/A Book Value$3.73 per share Price / Book1.17Miscellaneous Outstanding Shares10,140,000Free Float10,013,000Market Cap$44.21 million OptionableOptionable Beta1.16 Key ExecutivesMarlan WalkerChief Executive OfficerMichael DoneganChief Financial & Accounting OfficerDouglas Mike SteelmanVice President-Market AccessBharat WarrierChief Manufacturing OfficerKristen LandonVP-Marketing & Head-MediaKey CompetitorsGenprexNASDAQ:GNPXAtrecaNASDAQ:BCELProMIS NeurosciencesNASDAQ:PMNUnity BiotechnologyNASDAQ:UBXMedicenna TherapeuticsNASDAQ:MDNAView All CompetitorsInsiders & InstitutionsGeode Capital Management LLCBought 14,835 shares on 5/16/2023Ownership: 0.807%State Street CorpBought 3,600 shares on 5/16/2023Ownership: 0.297%Rubric Capital Management LPSold 565,000 shares on 5/15/2023Ownership: 11.763%Group One Trading L.P.Sold 5,800 shares on 5/12/2023Ownership: 0.000%Charles Schwab Investment Management Inc.Bought 8,064 shares on 5/12/2023Ownership: 0.518%View All Insider TransactionsView All Institutional Transactions TXMD Stock - Frequently Asked Questions Should I buy or sell TherapeuticsMD stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TherapeuticsMD in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TXMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TXMD, but not buy additional shares or sell existing shares. View TXMD analyst ratings or view top-rated stocks. How have TXMD shares performed in 2023? TherapeuticsMD's stock was trading at $5.59 at the start of the year. Since then, TXMD shares have decreased by 22.0% and is now trading at $4.36. View the best growth stocks for 2023 here. When is TherapeuticsMD's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our TXMD earnings forecast. How were TherapeuticsMD's earnings last quarter? TherapeuticsMD, Inc. (NASDAQ:TXMD) announced its quarterly earnings data on Monday, May, 15th. The company reported ($0.24) EPS for the quarter. The business had revenue of $0.42 million for the quarter. When did TherapeuticsMD's stock split? Shares of TherapeuticsMD reverse split on the morning of Monday, May 9th 2022. The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of TherapeuticsMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other TherapeuticsMD investors own include OPKO Health (OPK), Verastem (VSTM), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), Cleveland-Cliffs (CLF), Novavax (NVAX) and Micron Technology (MU). What is TherapeuticsMD's stock symbol? TherapeuticsMD trades on the NASDAQ under the ticker symbol "TXMD." Who are TherapeuticsMD's major shareholders? TherapeuticsMD's stock is owned by many different institutional and retail investors. Top institutional shareholders include Rubric Capital Management LP (11.76%), Tejara Capital Ltd (3.51%), Geode Capital Management LLC (0.81%), Group One Trading L.P. (0.00%), Charles Schwab Investment Management Inc. (0.52%) and Sanders Morris Harris LLC (0.36%). Insiders that own company stock include Brian Bernick, Cooper C Collins, Edward Borkowski, Gail K Naughton, James Darecca, Marlan D Walker, Marlan D Walker, Michael C Donegan, Michael C Donegan, Paul Bisaro, Robert G Finizio, Rubric Capital Management Lp, Tommy G Thompson and Tommy G Thompson. View institutional ownership trends. How do I buy shares of TherapeuticsMD? Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is TherapeuticsMD's stock price today? One share of TXMD stock can currently be purchased for approximately $4.36. How much money does TherapeuticsMD make? TherapeuticsMD (NASDAQ:TXMD) has a market capitalization of $44.21 million and generates $69.96 million in revenue each year. How many employees does TherapeuticsMD have? The company employs 416 workers across the globe. How can I contact TherapeuticsMD? TherapeuticsMD's mailing address is 951 Yamato Road Suite 220, BOCA RATON FL, 33431. The official website for the company is www.therapeuticsmd.com. The company can be reached via phone at (561) 961-1900, via email at shareholder@broadridge.com, or via fax at 561-431-3389. This page (NASDAQ:TXMD) was last updated on 6/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.